The alk package insert (b)(4) and interpretation guide (b)(4) mandate the use of system controls run with all patient samples.The package insert specifically calls out excessive non-specific background staining of glandular epithelial cells, muscle, or lymphoid tissue that interferes with scoring as unacceptable and instructs users that if the positive or negative tissue controls fail to demonstrate appropriate staining or demonstrate a change in clinical diagnostic interpretation, any results with the test specimens should be considered invalid.
|
From the investigation, there were no similar issues escalated against the complaint alk (d5f3) (06679072001) lot g10367.Additionally, retain materials were tested on appendix and alk-fusion positive/negative nsclc.The background, although, higher than a reference lot of material, did not interfere with specific staining of the tumor or lack thereof.It was determined by the rtd lead pathologist that although background was increased from the reference lot, it would not result in a false positive call.The alk interpretation guide addresses background staining and how to properly evaluate the control and patient specimen slides.The guide directs customers to repeat staining if the controls (system level and negative reagent controls) are not acceptable or if the alk-stained slide is not evaluable.The root cause was not identified for the increase in background of certain lots of reagent.However, based on results from multiple comparisons of raw material purified using different purification resins, a modification was incorporated into the purification process for the anti-alk (d5f3) rabbit monoclonal antibody raw material.Specifically, a change in the protein a resin used to purify the anti-alk (d5f3) rabbit monoclonal antibody raw material was implemented.Verification studies were performed and passed.(b)(4).
|